CV
ETTX

Clarus Ventures’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Clarus Ventures’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$17.7M Buy
+1,623,405
New +$17.1M 4.15% 6

Other funds holding ETTX

NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
LM
Luminus Management Houston, Texas $146M AUM 27.83% 1-Year Est. Return
HP
Hound Partners New York $863M AUM 11.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Clarus Ventures's ETTX Position: Q3 2018 in Review

Clarus Ventures opened a new position in Entasis Therapeutics Holdings Inc. (ETTX) in Q3 2018: 1,623,405 shares worth $17.7M. The stake represents 4.15% of the portfolio and ranks #6 among its holdings.

19 funds tracked by Wall St. Rank hold ETTX as of Q3 2018.

  • Clarus Ventures held 1,623,405 shares of Entasis Therapeutics Holdings Inc. worth $17.7M as of Q3 2018.
  • Entasis Therapeutics Holdings Inc. was a new Clarus Ventures position in Q3 2018.
  • Entasis Therapeutics Holdings Inc. made up 4.15% of Clarus Ventures's portfolio in Q3 2018, its #6 holding.
  • 19 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q3 2018.

Based on Clarus Ventures's 13F filing for Q3 2018, filed 14 Nov 2018.